DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (900.00%)
Oct 8, 2025, 3:39 PM EDT
DMK Pharmaceuticals Market Cap
DMK Pharmaceuticals has a market cap or net worth of $1.01 thousand as of October 8, 2025. Its market cap has decreased by -99.98% in one year.
Market Cap
1.01K
Enterprise Value
n/a
Revenue
3.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 3, 2009, DMK Pharmaceuticals's market cap has decreased from 29.45M to 1.01K, a decrease of -100.00%. That is a compound annual growth rate of -46.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 1.01K | 9,990.00% |
| Dec 31, 2024 | 10.00 | -100.00% |
| Dec 29, 2023 | 7.07M | -72.16% |
| Dec 30, 2022 | 25.39M | -71.81% |
| Dec 31, 2021 | 90.08M | 98.26% |
| Dec 31, 2020 | 45.43M | 5.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |